FAMULARO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 427
EU - Europa 144
AS - Asia 45
SA - Sud America 2
Totale 618
Nazione #
US - Stati Uniti d'America 424
IT - Italia 84
IN - India 21
UA - Ucraina 20
SE - Svezia 18
CN - Cina 13
FI - Finlandia 11
SG - Singapore 6
FR - Francia 4
TR - Turchia 4
NL - Olanda 3
AR - Argentina 2
CA - Canada 2
IE - Irlanda 2
BG - Bulgaria 1
DE - Germania 1
IR - Iran 1
MX - Messico 1
Totale 618
Città #
Fairfield 77
Ashburn 44
Seattle 38
Woodbridge 34
Chandler 33
Ann Arbor 20
Cambridge 19
Rome 15
Houston 14
Princeton 14
Wilmington 14
Beijing 11
Plano 11
Dearborn 8
Des Moines 8
Cervere 7
Jacksonville 7
Lawrence 6
Millbury 6
San Paolo di Civitate 6
Boston 5
Istanbul 4
Salerno 4
Verona 4
Andover 3
Deiva Marina 3
Fasano 3
Florence 3
Milan 3
Norwalk 3
Palermo 3
Paris 3
San Diego 3
Vigodarzere 3
Bari 2
Bergamo 2
Calvisano 2
Catanzaro 2
Dalmine 2
Dublin 2
Federal 2
Genoa 2
Leawood 2
Los Angeles 2
Ovada 2
Pescorocchiano 2
Rimini 2
Singapore 2
Toronto 2
Bonndorf 1
Falls Church 1
Fremont 1
Hefei 1
Helsinki 1
Indiana 1
Kish 1
Le Casine-Perignano-Spinelli 1
Le Petit-Quevilly 1
Malnate 1
Pune 1
Santa Marinella 1
Sesto Fiorentino 1
Shenyang 1
Sofia 1
Washington 1
Totale 485
Nome #
Lymphocyte apoptosis, caspase activation and inflammatory response in septic shock 94
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting. evidence from the REPOSI register 86
Probiotics for the hemodynamic alterations of patients with liver cirrhosis. 70
CARNITINE DEFICIENCY IN SCLERODERMA 69
Oxidative stress and mitochondrial glutathione in human lymphocytes exposed to clinically relevant anesthetic drug concentrations 61
Cyclosporin A-H2 receptor antagonists drug interaction in the sprague-dawley rat. 58
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis. 51
Polyclonal B lymphocyte activation in progressive systemic sclerosis. 39
Imbalance of immune functions in progressive systemic sclerosis patients 36
Altered carnitine status in patients with systemic sclerosis 23
Alterato metabolismo delle carnitine in pazienti affetti da sclerosi sistemica 23
Livelli plasmatici di peptide vasoativo intestinale (VIP) nei pazienti affetti da sclerosi sistemica 20
Totale 630
Categoria #
all - tutte 1.954
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.954


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201946 0 0 0 0 0 0 0 0 0 0 27 19
2019/2020138 19 2 1 7 14 23 16 17 15 9 13 2
2020/202144 6 6 2 2 4 3 3 3 2 6 4 3
2021/2022102 0 5 8 3 13 2 2 13 7 11 18 20
2022/2023122 26 21 4 9 12 16 2 9 12 0 11 0
2023/2024123 2 15 11 6 15 20 5 20 2 18 9 0
Totale 630